Haberler2017 “TÜBA Ödülleri” Sahiplerini Buldu Doç. Dr. Ayata’dan “Beyin Hasarı Depolarizasyonları” Başlıklı “Akademi Ödülü Konferansı” TÜBA Başkanlık Açıklaması Doç. Dr. Ayata’dan “Akademi Ödülü Konferansı” Prof. Hamza’dan “Akademi Ödülü Konferansı” “TÜBA 2017 Ödülleri” Açıklandı TÜBA-GEBİP ve TESEP Ödülleri için 2018 Yılı Başvuruları Başladı TÜBA Asli Üyesi Prof. Savaş Uşak Üniversitesi Rektörlüğü'ne Atandı Ahmet Yesevi Üniversitesi Mütevelli Heyet Başkanı Prof. Yıldız'dan TÜBA’ya Ziyaret BEÜ Rektör V. Prof. Dr. Ali Azar'dan TÜBA’ya Ziyaret
TÜBA Phase Studies and Ethical Rules Workshop on Clinical Studies was Held
Tarih: 19 OCAK 2017 Okunma Sayısı: 5251
TÜBA Phase Studies and Ethical Rules Workshop on Clinical Studies started on 13 January at The Green Park Hotel, Pendik and ended with the General Evaluation Meeting held on 14 January following the moderator presentations.
The workshop, which aims to contribute to the conduct of clinical trials in Turkey in accordance with the relevant rules, to increase the scientific impact of Turkey in the world, to develop the national pharmaceutical industry, to product biosimilar products and to increase the utilization rate of Turkey from international research funds, lasted two days.
12 different topics including patient and public awareness, studies conducted on animals, cellular therapy and regenerative medicine, ethical rules in studies conducted with biosimilar drugs, non-drug clinical studies were examined with the participation of around 200 scientists and administrators at the workshop. The Social Security Institution (SGK), the Ministry of Science, Industry and Technology, the Ministry of Health, the Turkish Medicines and Medical Devices Agency (TİTCK), universities as well as associations took part in the workshop.
Deputy Minister of Science, Industry and Technology Assoc. Prof. Hasan Ali Celik: "Science must be based on honesty and honesty."
TÜBA President Prof. Acar: “A huge capital is turning at drugs and health sector.”
TÜBA President Prof. Ahmet Cevat Acar also stated that Turkey should be brought to an innovative level especially in the fields of medicine and health so as to be among the innovative economies.
Emphasizing the return of a huge capital, especially in drug and the health sector in general, Prof. Acar said: "Some global companies are able to enter into open and covered operations at the expense of violating the law, and of course we should not give a reason to our own temptation. It is obvious that such a commercialized area, which is the most basic and most natural human right, such as health, also has many drawbacks. Our workshop will provide important contributions to our country and humanity.”
Prof. Demirer "The workshop report will be an important reference source."
The studies lasted until late
The conferences, "Phase Studies in Clinical Investigations and Problems in Our Country" by Prof. Taner Demirer, "Evaluation of the Results of the TİTCK Ethical Committees Workshop" by Clinical Research Department Head Nihan Burul Bozkurt and "Drug Investigations Made on Human Beings at Pharmaceutical Sector Perspective" by Representative of Investigative Drug Firms Association (AİFD) Hülya Demiral were also held at workshop.